Myriad Genetics
MYGN
#7325
Rank
A$0.67 B
Marketcap
A$7.27
Share price
0.39%
Change (1 day)
-63.44%
Change (1 year)

Earnings for Myriad Genetics (MYGN)

Earnings in 2025 (TTM): -A$0.65 Billion

According to Myriad Genetics's latest financial reports the company's current earnings are A$0.82 Billion. In 2024 the company made an earning of -A$0.18 Billion, an increase over its 2023 earnings that were of -A$0.37 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Myriad Genetics from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.65 Billion274.65%
2024 -A$0.18 Billion-53.49%
2023 -A$0.37 Billion88.72%
2022 -A$0.2 Billion172.08%
2021 -A$71.73 Million
2019 -A$37.36 Million-175.14%
2018 A$49.71 M-70.81%
2017 A$0.17 B22.22%
2016 A$0.13 B-38.8%
2015 A$0.22 B-6.12%
2014 A$0.24 B-41.07%
2013 A$0.41 B46.67%
2012 A$0.28 B15.84%
2011 A$0.24 B17.6%
2010 A$0.20 B-15.96%
2009 A$0.24 B
2007 -A$59.2 Million40.96%
2006 -A$42 Million
2003 -A$48.77 Million34.8%
2002 -A$36.18 Million89.21%
2001 -A$19.12 Million3.93%
2000 -A$18.4 Million21.76%
1999 -A$15.11 Million-25.61%
1998 -A$20.32 Million38.83%
1997 -A$14.63 Million-24.26%
1996 -A$19.32 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Abbott Laboratories
ABT
A$11.55 B-2,044.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
-A$1.38 Billion 131.78%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.96 B-262.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-A$49.67 Million-91.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
-A$1.2 Billion 101.34%๐Ÿ‡บ๐Ÿ‡ธ USA